NP47926 Biologic, Biosimilar’s and Methotrexate Injections
Supply of Biologics, Biosimilars and Methotrexate Injections to NHS Scotland.
Buyer
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
Value
£334,866,015
Published
21 Sept 2026
Closes
21 Oct 2026
Procurement details
Source
Pcs
Region
Scotland
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
33650000
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33690000
Various medicinal products
33652000
Antineoplastic and immunomodulating agents
Lots
Lot 8 Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Device
Value not provided
Supply of Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Device to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 5 Infliximab Subcutaneous Injection
£18,830,820
Supply of infliximab subcutaneous injection to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 9 Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Syringe
£14,565
Supply of Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Syringe to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 6 Methotrexate (50mg/1ml concentration) Pre-Filled Self Injection Device
£3,719,554
Supply of Methotrexate (50mg/1ml concentration) Pre-Filled Self Injection Device to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 7 Methotrexate (50mg/1ml concentration) Pre-Filled Syringe
£2,071
Supply of Methotrexate (50mg/1ml concentration) Pre-Filled Syringe to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 1 Adalimumab
£68,840,541
Supply of adalimumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 7 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 2 Etanercept
£56,785,379
Supply of etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 5 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 3 Golimumab
£17,468,277
Supply of golimumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 4 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 4 Infliximab Intravenous Infusion
£30,991,783
Supply of infliximab intravenous infusion to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 6 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 10 Omalizumab
£18,669,166
Supply of omalizumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 4 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 12 Tocilizumab
£46,446,380
Supply of tocilizumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 5 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 13 Ustekinumab
£68,865,598
Supply of ustekinumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 9 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 11 Tildrakizumab
£4,231,882
Supply of tildrakizumab to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Documents
Unlock document linkNP47926 Biologic, Biosimilar’s and Methotrexate Injections
Not provided
Supply of Biologics, Biosimilars and Methotrexate Injections to NHS Scotland.
Contract notice · Web page